Skip to main content

Table 1 Prevalence rate of HBV & HCV positivity among HIV+ patient

From: Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients

   HBsAg+ Anti-HCV+ Double Positive
Variable N (Percent) N P N P N P
Total 391(100%) 57(14.5%)   282 (72%)   31 (7.9%)  
Sex    <0.001   <0.001   <0.001
   Male 358 (91.6%) 40(11.2%)   274(76.5%)   24 (6.7%)  
   Female 33 (8.4%) 17(51.5%)   8 (24.3%)   7 (21.2%)  
Age    0.013   <0.001   <0.001
   ≤ 30 140 (35.8%) 18(12.9%)   108 (77.2%)   8 (5.7%)  
   31-50 204 (52.1%) 27(13.2%)   151 (74%)   18 (8.9%)  
   ≥ 50 47 (12%) 12(25.5%)   23 (48.9%)   5 (10.6%)  
Marital status    <0.001   <0.001   <0.001
   Single 195 (49.8%) 14(7.2%)   160 (82%)   11(5.7%)  
   Married 166 (42.4%) 40(24%)   99 (59.7%)   18 (10.6%)  
   Other 30 (7.6%) 3 (10%)   23 (76.7%)   2 (6.7%)  
Risk Factor    <0.001   <0.001   <0.001
   IDU 202 (51.6%) 12 (5.9%)   172 (85.2%)   8 (3.1%)  
   Sexual 11 (2.8%) 4 (3.4%)   3 (27.3%)   1 (9%)  
   Transfusion 12 (3%) 0 (0%)   12 (100%)   0 (0%)  
   Sex & IDU 56 (14.3%) 6 (10.7%)   36 (64.3%)   13(23.2%)  
   Pregnant 5 (1.2%) 2 (40%)   0 (0%)   0 (0%)  
   Other 105 (26.8%) 33(31.5%)   59 (56.2%)   9 (8.6%)  
Occupation    <0.001   <0.001   <0.001
   Unemployed 221 (56.5%) 16 (7.2%)   174 (78.7%)   15 (6.8%)  
   Self employed 63 (16.1%) 8 (12.7%)   47 (74.6%)   4 (6.3%)  
   Worker 42)10.7%) 6 (14.3%)   33 (78.6%)   3 (7.2%)  
   Employee 3 (0.7%) 1) 33.3%)   2 (66.7%)   0) 0%)  
   housewife 32 (8.1%) 16 (50%)   8) 25%)   7 (21.9%)  
   Farmer 4 (1%) 4 (100%)   0 (0%)   0 (0%)  
   Student 12 (3%) 3 (25%)   9 (75%)   0 (0%)  
   Driver 10 (2.5%) 2 (20%)   6 (60%)   20 (20%)  
   Other 4 (1%) 1 (25%)   3 (75%)   0 (0%)  
  1. HBsAg: HBV surface antigen, anti-HCV: antibody against HCV, N: number of patients, p: p-value, IDU: Injection drugs users